Background/Objectives: Coffee is known to contain antioxidant substances whose effects may be blunted because of caffeine that may unfavorably affect the cardiovascular system. This study was designed to investigate the acute dose-dependent effects of decaffeinated coffee (DC) on endothelial function measured by the brachial artery flow-mediated dilation (FMD). Subjects/Methods: A total of 15 (8 men and 7 women) healthy nonobese subjects underwent a single-blind, crossover study. Subjects ingested one and two cups of decaffeinated Italian espresso coffee in random order at 5-to 7-day intervals. Results: In the hour following the ingestion of two cups of DC, FMD increased (mean±s.e.m.): 0 min, 7.4±0.7%; 30 min, 8.0 ± 0.6%; 60 min, 10.8 ± 0.8%; Po0.001) as compared to consumption of one cup of DC (0 min, 6.9 ± 0.7%; 30 min, 8.4±1.2%; 60 min, 8.5±1.1%; 3 Â 2 repeated-measures analysis of variance: P ¼ 0.037 for time Â treatment effect). Blood pressure did not differ between groups, and basal heart rate was lower in the two-cup group at baseline and 60 min.
Introduction
The effect of coffee on cardiovascular metabolism and disease has been controversial (Bonita et al., 2007; Klatsky et al., 2008) . Epidemiological investigations (Silletta et al., 2007; Larsson et al., 2008; van Woundenbergh et al., 2008) have generally indicated the protective effects of coffee on the development of cardiovascular diseases (CVD), however, short-term studies have shown otherwise (Mukamal et al., 2004; Zampelas et al., 2004) . A possible explanation of these conflicting reports may be that coffee contains different compounds with opposing cardiovascular effects. Acutely, caffeine may induce unfavorable cardiovascular responses such as increased blood pressure and heart rate, but substances such as the chlorogenic acids that possess antioxidant properties may have long-term protective effects (Fujioka and Shibamoto, 2008 ). An impaired regulation between the balance of oxidant and antioxidant substances is characteristic of endothelial dysfunction that may be a key step in understanding the pathogenesis of atherosclerosis, hypertension and heart failure (Fuchgott and Zawadzki, 1980; Deanfield et al., 2007) . Traditional cardiac risk factors induce endothelial dysfunction, defined by a reduced bioavailability of nitric oxide, either because of reduced production, increased inactivation or both (Fuchgott and Zawadzki, 1980; Deanfield et al., 2007) . In this context, it is not well defined if dietary antioxidants may have a protective role on endothelial function and CVD.
We recently investigated the acute effects of espresso coffee compared to decaffeinated coffee (DC) on endothelial function measured in vivo as flow-mediated dilation (FMD) of the brachial artery (submitted, Eur J Clin Nutr) to validate the only other study currently examining the comparative impact of caffeinated and DC on endothelial function (Papamichael et al., 2005) . As DC ingestion led to a nonsignificant rise in brachial artery FMD, we hypothesized that antioxidant substances contained in either brand of coffee acutely improve endothelial function. In this study, we investigated the acute dose-dependent effects of DC on endothelial function following administration of decaffeinated espresso coffee in healthy subjects.
Materials and methods

Subjects
A total of 15 nonobese healthy hospital employees voluntarily participated in the study after responding to our medical center announcement. There was no incentive provided to the participants. . Exclusion criteria included patients with any dyslipidemia, hypertension, diabetes, cardiovascular or systemic disease, any medication treatment, smoking of any tobacco products, pregnancy or lactation in the past 6 months, habitual daily consumption of more than 2 cups of coffee, weekly ingestion of more than one commercial caffeinated beverage, abstaining from chocolate or other flavonoid containing beverages the day preceding the measurements. The study protocol was approved by the ethics committee of the University Hospital Policlinico P. Giaccone of Palermo, Italy, and an approved informed consent form was signed by each subject. This study is registered as an International Standardized Randomized Controlled Trial (ISRCTN41583899).
Study design
The study followed a randomized, crossover, single-blind design with each subject receiving two different study treatments, in random order, and repeated on separate days at 5-to 7-day intervals. Anthropometric measurements, routine blood tests and an oral glucose (75 g) tolerance test were carried out in all subjects before participating in the study by MRT, SB, RR, AR, and GP who were blinded to study participant randomization. Subjects were tested in the morning after an overnight fast. FMD of the brachial artery was performed by the same investigator (SB) at baseline, 30 and 60 min after drinking one or two cups of Italian espresso DC. Ultrasound images were video-recorded and analyzed by a trained reader who was blinded to the participant's amount of coffee tested (SV). Subjects had a continuous electrocardiogram, systolic and diastolic blood pressures (10 min intervals) recorded for the duration of each test. Pulse pressure was calculated as the difference between peripheral systolic and diastolic blood pressure.
Biochemical measurements
Venous plasma glucose concentrations were measured before and at 60 min after DC ingestion using the glucose oxidase method (Instrumentation Laboratory, Milano, Italy).
Basal lipid measurements and uric acid were ascertained using common clinical chemistry methods (IL test CHOL; IL test HDL-CHOL; IL test triglycerides; IL test uric acid; Instrumentation Laboratory). Low-density lipoprotein (LDL) cholesterol concentration was calculated according to the Friedewald formula (Friedewald, 1972) .
Coffee testing
Fresh DC was prepared using a commercial automatic machine (Easy Serving Espresso, Palermo, Italy) by a study nurse. One cup of coffee consisted of 25 ml of espresso obtained with an average extraction time of 20 s from 7 g of a coffee mixture pressed in packet. Each packet of DC contained a mixture of 65% Robusta (variety Canephora) and 35% Arabica (A Morettino SpA, Palermo, Italy). The average caffeine content in 25 ml of DC measured by chromatography and spectrophotometry (Chemical Laboratory, Camera di Commercio Industria Artigianato e Agricoltura, Trieste, Italy) was 5 mg. No addition of sugar or milk was permitted.
Measurements
Body circumference was obtained at the umbilicus (waist circumference) and at the most prominent buttock level (hip circumference). Endothelium-dependent reactivity in the macrocirculation, measured by FMD of the brachial artery, was determined using high-resolution vascular ultrasound (Sonoline G50; Siemens, Erlangen, Germany) with a 10 MHz linear array transducer. The transducer was held at the same position throughout the test by a stereotactic clamp with micrometer adjustment (EDI Progetti e Sviluppo, Pisa, Italy) to ensure image consistency. Reactive hyperemia was produced by inflating a sphygmomanometer cuff 2 cm below the antecubital fossa to occlude the artery for 5 min at approximately 220-250 mm Hg, then deflating it. A video processing system computed the brachial artery diameter in real time by analyzing B-mode ultrasound images (FMD Studio, Institute of Physiology CNR, Pisa, Italy). Briefly, the device captures the analogue video signal from the ultrasound equipment. An edge detection algorithm, based on the localization of gray-level discontinuities, automatically locates the two walls of the vessel. The diameter is obtained with subpixel precision and temporal resolution of 25 samples per second. The brachial artery diameters were displayed on a graphical interface over a time scale of 9 min. Baseline vessel size was considered the mean of the measures obtained during the first minute. The FMD was calculated as the maximum percentage of increase of brachial artery diameter over baseline. These procedures are described in detail elsewhere (Corretti et al., 2002; Barac et al., 2007; Deanfield et al., 2007; Buscemi et al., 2009) . The intraobserver coefficient of variation for FMD was 2.9% in our laboratory.
Statistical analysis
All data are presented as means±standard error of means. Basal pair-wise comparisons between the two treatments (one cup vs two cups of DC) were tested for statistical significance using the paired Student's t-test. An overall 3 Â 2 repeated-measures analysis of variance (ANOVA) was performed to evaluate the composite effect of the amount of DC ingested (one cup vs two cups of DC) over time (three periods: baseline, 30 and 60 min) on the parameters of interest. Repeated-measures ANOVA was also carried out to detect significant changes in variables over time within the two sessions separately; Bonferroni's t-test was performed for individual differences between two time points (paired) when appropriate. A two-tailed Po0.05 was considered statistically significant. An expected difference in FMD within each experiment group due to the amount of DC ingested was estimated to be 2.5% with a standard deviation of 2.0. The power analysis showed that with an a of 0.05 and a power of 0.80, 12 subjects were needed to be investigated. All analyses were performed using Systat (Windows, version 11.0; Systat Software Inc., San Jose, CA, USA).
Results
The physical and clinical characteristics of study participants are reported in Table 1 . The effects of ingested DC on FMD and other measured variables are shown in Table 2 and Figure 1 . Basal blood pressure (systolic and diastolic) did not differ between groups, systolic blood pressure significantly decreased after two cups of DC (Po0.001) whereas diastolic blood pressure increased after one cup of DC (Po0.001). Pulse pressure decreased significantly (P ¼ 0.028) after one cup of DC and not significantly after two cups of DC (P ¼ 0.17). Basal heart rate was lower in the two-cup group at baseline. No significant treatment effect was observed on systolic and diastolic blood pressure, pulse pressure and heart rate. Fasting plasma glucose did not change 1 h after ingestion of either one cup (basal: 83 ± 1 vs 60 min: 84±2 mg/100 ml; P ¼ 0.79) or two cups (basal: 85±2 vs 60 min: 83 ± 2 mg/100 ml; P ¼ 0.21) of DC.
Flow-mediated dilation was no higher following ingestion of one cup of DC at follow-up (P ¼ 0.11) but increased significantly in the two-cup group (Po0.001). FMD was significantly higher in the two-cup group than in the onecup group at 60 min (P ¼ 0.04). In the two-cup group, the FMD at 60 min was significantly higher than at baseline (Po0.000) and at 30 min (Po0.004) (Figure 1) . A significant treatment effect was observed on FMD (Table 2) .
Discussion
The present study demonstrated a significant favorable dosedependent effect of consuming decaffeinated espresso coffee on endothelial function. Substances contained in coffee, presumably the chlorogenic acids that have antioxidant effects, exert a positive action on the endothelium, which is likely favorable in further enhancing our understanding of the underlying abnormalities of endothelial dysregulation in cardiovascular and metabolic diseases. Our results suggest that DC may acutely improve endothelial function in all likelihood due to such antioxidants.
Brachial artery FMD is a reference method for in vivo measurements of endothelial function in humans and has been shown to predict cardiovascular events (Gokce et al., 2002; Widlansky et al., 2003; Yeboah et al., 2007; Rossi et al., 2008) . Endothelial function following ingestion of two cups of DC demonstrated a progressive increase of 45% above baseline values. Interestingly, there was a nonsignificant, yet profound 23% mean increase in FMD after the ingestion of only one cup of DC at 1 h. Whether this effect reached a plateau is unknown but potentially this relationship may have more amplitude or be ascertained if measured continuously or past the 1 h mark. Following the ingestion of two cups of DC the FMD reached the peak value at 1 h being not significantly changed at 30 min of FMD. Although frequent measurements of FMD may lead to excessive patient discomfort, future studies that aim to Decaffeinated coffee and FMD S Buscemi et al investigate the time duration of increased FMD may extend measurements at 2 and 3 h avoiding those at 30 min. Papamichael et al. (2005) were the first to examine the effect of both caffeinated and decaffeinated instant coffees, not expresso as in ours, on endothelial function using similar techniques but in fact measured FMD up to 120 min. However, they did not demonstrate any changes in FMD in the decaffeinated group, nor did they examine the dosedependent effects of multiple cups of DC. In addition, their study population may have been impacted by certain confounding variables as participants were abstaining from caffeinated products for 12-24 h before participation, which may question the validity of their results. A small number of other studies have examined similar proposing hypotheses but their study design and outcomes differed than ours Umemura et al., 2006) . Study participants in one study abstained from nicotine for only 24 h (Umemura et al., 2006) , a compound known to affect endothelial function despite smoking cessation. Both Karatzis and Vlachopoulos et al. (2005) examined the impact of caffeine on arterial wave forms but not specifically on endothelial function. Karatzis did not observe any effect on their augmentation index or waveforms in the decaffeinated groups. Finally, Mahmud and Feely (2001) demonstrate in only seven subjects the impact of both caffeinated and DC on arterial stiffness and not FMD. Such differences in study design and outcomes make comparisons to our own study rather difficult to make and none of these studies demonstrate dose-dependent effects of DC on FMD.
As participants in this study were healthy volunteers that were not habitual consumers of DC, we cannot therefore Heart rate (beats/min) 0.009 0.31 Basal 69±2 6 6 ±2* 30 min 69 ± 1 6 8 ± 2 60 min 68 ± 2 6 5 ± 2
Flow-mediated dilation (%) 0.000 0.037 Basal 6.9 ± 0.7 7.4 ± 0.7 30 min 8.4 ± 1.2 8.0 ± 0.6 60 min 8.5 ± 1.1 10.8 ± 0.8
All values are mean ± s.e.m. *Student's paired t-test: Po0.05 vs one-cup treatment. The effect was significant (Po 0.001, one-way ANOVA) for two cups of decaffeinated coffee with a significant difference observed at 60 min compared with 0 min (Po0.000) and 30 min (P ¼ 0.004; Bonferroni's t-test). *Po0.05 significant difference between one and two cups of decaffeinated coffee.
Decaffeinated coffee and FMD S Buscemi et al exclude that tolerance mechanisms may mitigate the effects of DC on prolonged FMD. However, other foods and beverages that contain natural antioxidants seem to exclude the possibility that they have a reduced effect on FMD with chronic use. Kim et al. (2006) demonstrated that the consumption of 8 g per day (about eight cups) of green tea for 2 weeks improved FMD by 29%. Similarly, FMD was increased after flavanol-rich dark chocolate consumption (100 g per day) for 15 days (Grassi et al., 2008) . In general, only slight changes in blood pressure and heart rate were observed after DC ingestion, but this study does not show univocal conclusions. The ingestion of two cups of DC induced a significant reduction of systolic blood pressure and heart rate, especially at 1 h in the latter case. However, diastolic blood pressure increased after the ingestion of one cup of DC and this remains a contradictory result without a clear interpretation. When pulse pressure variation was considered, we observed a slight reduction after DC ingestion with a significant time effect without any significant treatment effect. Because pulse pressure reflects arterial stiffening, the latter seems not to be influenced by the DC dose. The pulse pressure reduction might rather have been a consequence of a progressive reduction of adrenergic tone due to relaxation, as the significant reducing time effect on heart rate might suggest. Owing to both the small effect we observed on blood pressure and also due to our small sample size, we were insufficiently powered to demonstrate any statistically significant changes. Further studies on larger samples of subjects with hypertension may give a conclusive answer about the effects of DC on blood pressure and heart rate.
Despite the favorable acute effects of DC on FMD, and possibly to a limited extent on systolic blood pressure and heart rate, we cannot extrapolate our results to chronic DC consumption on patient health. Furthermore, we did not measure antioxidant concentrations during the study, nor were we able to obtain them from the manufacturer. As such, we can only hypothesize that this was the reason why FMD improved in a dose-dependent effect acutely. Whether certain antioxidants are responsible for such effects is unknown. In addition, whether this can be further generalized to all other antioxidant supplementations, who themselves may have possible safety and tolerability problems (Vivekananthan et al., 2003; Bjelakovic et al., 2004; Miller et al., 2004) that can have an impact on cardiovascular metabolism, is unclear. Clearly, interaction with other foods is highly possible. For instance, studies have demonstrated the antioxidant capacity of dark chocolate and green and black tea, all are also strongly reduced by milk (Serafini et al., 1996 (Serafini et al., , 2003 Langley-Evans, 2000) . By omitting the addition of milk, we possibly may have had a homogenous sample that could accurately lead to proper function. However, although the above statements are likely physiologically plausible, they are undoubtedly speculative and should not be considered causative.
Our study had two major limitations. We did not include a corresponding control or placebo group, to which we could compare the effects of DC. Ideally, this would allow us to have a prespecified end point or effect. Although we are unaware of any studies that indeed contrast these entities, we partially deal this with the reproducibility of FMD in each group. Alternatively, such a study was a natural follow-up to a previous study evaluating the differences on FMD between caffeinated coffee and DC (Buscemi et al., submitted, Eur J Clin Nutr) .
This study is to the best of our knowledge the first to compare the acute dose-dependent effects of DC on FMD with a randomized, crossover, single-blind design. Owing to the different volumes of DC tested, it was not possible to design a double-blind study, however we feel that the knowledge of the amount of DC ingested by the study participants could not elicit or influence different FMD responses per se. Our study was meant to be an exploratory one and our results should be interpreted with caution. Larger sample sizes would be needed to ascertain fully this relationship on FMD.
Caffeinated and decaffeinated espresso coffee appear to have opposing effects on FMD. This may have possible health implications considering the number of persons consuming coffee worldwide. In particular, also DC might be included among those foods or beverages that are known to have antioxidant effect or a favorable influence on endothelial function. In patients with CVD, DC may in fact be a safer alternative than caffeinated coffee, although specific studies examining these relationships in this population would be needed. Further studies are needed to investigate the effects of chronic use of DC especially with respect to caffeinated coffee and in subjects with CVD.
